Neumora Therapeutics, INC. (NMRA) SEC Filings — 2024
13 SEC filings for Neumora Therapeutics, INC. (NMRA) in 2024.
Filings
- Arch Venture Fund XII Updates Neumora Holdings Filing — SC 13D/A · Nov 22, 2024
- Neumora Therapeutics, INC. SC 13G Filing — SC 13G · Nov 12, 2024
- Neumora Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Neumora Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
- Neumora Therapeutics Reports on Shareholder Vote — 8-K · Jun 14, 2024
- Neumora Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Neumora Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 25, 2024
- Neumora Therapeutics Closes $349.6M Public Offering — 8-K · Apr 15, 2024
- Neumora Therapeutics Files 8-K on Financials — 8-K · Mar 7, 2024
- Neumora Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 7, 2024
- Neumora Therapeutics, INC. SC 13G Filing — SC 13G · Feb 14, 2024
- Neumora Therapeutics, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Neumora Therapeutics Confirms Nasdaq Listing for NMRA Stock — 8-K · Jan 8, 2024